LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...
A new study suggests that methylene blue—a medication already approved for several clinical uses—may protect the lungs from damage caused by major heart surgeries that involve stopping blood ...
As growing numbers of patients face multiple serious illnesses, researchers are finding new ways to unite heart and lung treatments for better outcomes in an ageing society. For a person with ...
De Andre Johnson’s 32-year-old body has been transformed into a patchwork quilt. The Newbury Park man’s diseased heart was replaced in a marathon transplant surgery in January at Cedars-Sinai Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results